BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kunisaki KM, Niewoehner DE, Collins G, Aagaard B, Atako NB, Bakowska E, Clarke A, Corbelli GM, Ekong E, Emery S, Finley EB, Florence E, Infante RM, Kityo CM, Madero JS, Nixon DE, Tedaldi E, Vestbo J, Wood R, Connett JE; INSIGHT START Pulmonary Substudy Group. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial. Lancet Respir Med 2016;4:980-9. [PMID: 27773665 DOI: 10.1016/S2213-2600(16)30319-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Kayongo A, Wosu AC, Naz T, Nassali F, Kalyesubula R, Kirenga B, Wise RA, Siddharthan T, Checkley W. Chronic Obstructive Pulmonary Disease Prevalence and Associated Factors in a Setting of Well-Controlled HIV, A Cross-Sectional Study. COPD 2020;17:297-305. [PMID: 32462945 DOI: 10.1080/15412555.2020.1769583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Singhvi D, Bon J, Morris A. Obstructive Lung Disease in HIV-Phenotypes and Pathogenesis. Curr HIV/AIDS Rep 2019;16:359-69. [PMID: 31256349 DOI: 10.1007/s11904-019-00456-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
3 MacDonald DM, Zanotto AD, Collins G, Baker JV, Czarnecki M, Loiza E, Nixon DE, Papastamopoulos V, Wendt CH, Wood R, Kunisaki KM; INSIGHT START Pulmonary Substudy Group. Associations between baseline biomarkers and lung function in HIV-positive individuals. AIDS 2019;33:655-64. [PMID: 30601153 DOI: 10.1097/QAD.0000000000002101] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
4 Sussenbach AE, van Gijzel SW, Lalla-edward ST, Venter WD, Shaddock E, Feldman C, Klipstein-grobusch K, Vos AG. The influence of smoking and HIV infection on pulmonary function. Southern African Journal of HIV Medicine 2022;23. [DOI: 10.4102/sajhivmed.v23i1.1329] [Reference Citation Analysis]
5 Hodgson S, Griffin TJ, Reilly C, Harvey S, Witthuhn BA, Sandri BJ, Kunisaki KM, Wendt CH. Plasma sphingolipids in HIV-associated chronic obstructive pulmonary disease. BMJ Open Respir Res 2017;4:e000180. [PMID: 28409005 DOI: 10.1136/bmjresp-2017-000180] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
6 Presti RM, Flores SC, Palmer BE, Atkinson JJ, Lesko CR, Lau B, Fontenot AP, Roman J, McDyer JF, Twigg HL 3rd. Mechanisms Underlying HIV-Associated Noninfectious Lung Disease. Chest 2017;152:1053-60. [PMID: 28427967 DOI: 10.1016/j.chest.2017.04.154] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
7 Fitzpatrick ME, Kunisaki KM, Morris A. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy. AIDS 2018;32:277-92. [PMID: 29194119 DOI: 10.1097/QAD.0000000000001712] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 8.8] [Reference Citation Analysis]
8 Lundgren JD, Borges AH, Neaton JD. Serious Non-AIDS Conditions in HIV: Benefit of Early ART. Curr HIV/AIDS Rep 2018;15:162-71. [PMID: 29504063 DOI: 10.1007/s11904-018-0387-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
9 Samperiz G, Fanjul F, Valera JL, Lopez M, Rios Á, Peñaranda M, Campins A, Riera M, Agusti A. Increased rate of FEV1 decline in HIV patients despite effective treatment with HAART. PLoS One 2019;14:e0224510. [PMID: 31661533 DOI: 10.1371/journal.pone.0224510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Varkila MRJ, Vos AG, Barth RE, Tempelman HA, Devillé WLJ, Coutinho RA, Grobbee DE, Klipstein-Grobusch K. The association between HIV infection and pulmonary function in a rural African population. PLoS One 2019;14:e0210573. [PMID: 30645622 DOI: 10.1371/journal.pone.0210573] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Kunisaki KM, Baker JV, Collins G, MacDonald DM, Bakowska E, El Filali KM, Nnakelu E, La Rosa A, Connett JE. Lung Function Decline in Early HIV Infection: Impact of Antiretroviral Drug Timing and Drug Regimen. Am J Respir Crit Care Med 2020;201:739-41. [PMID: 31841641 DOI: 10.1164/rccm.201911-2266LE] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Gupte AN, Wong ML, Msandiwa R, Barnes GL, Golub J, Chaisson RE, Hoffmann CJ, Martinson NA. Factors associated with pulmonary impairment in HIV-infected South African adults. PLoS One 2017;12:e0184530. [PMID: 28902919 DOI: 10.1371/journal.pone.0184530] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
13 Kunisaki KM, Nouraie M, Jensen RL, Chang D, D'Souza G, Fitzpatrick ME, McCormack MC, Stosor V, Morris A. Lung function in men with and without HIV. AIDS 2020;34:1227-35. [PMID: 32287070 DOI: 10.1097/QAD.0000000000002526] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
14 Byanova K, Kunisaki KM, Vasquez J, Huang L. Chronic obstructive pulmonary disease in HIV. Expert Rev Respir Med 2021;15:71-87. [PMID: 33167728 DOI: 10.1080/17476348.2021.1848556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Gisslén M, Hunt PW. Antiretroviral Treatment of Acute HIV Infection Normalizes Levels of Cerebrospinal Fluid Markers of Central Nervous System (CNS) Inflammation: A Consequence of a Reduced CNS Reservoir? J Infect Dis 2019;220:1867-9. [PMID: 30668742 DOI: 10.1093/infdis/jiz031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Antoniou T, Yao Z, Raboud J, Gershon AS. Incidence of chronic obstructive pulmonary disease in people with HIV in Ontario, 1996-2015: a retrospective population-based cohort study. CMAJ Open 2020;8:E83-9. [PMID: 32071142 DOI: 10.9778/cmajo.20190028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Rylance S, Rylance J, McHugh G, Majonga E, Bandason T, Mujuru H, Nathoo K, Rowland-Jones S, Henrion MYR, Simms V, Ferrand RA. Effect of antiretroviral therapy on longitudinal lung function trends in older children and adolescents with HIV-infection. PLoS One 2019;14:e0213556. [PMID: 30897116 DOI: 10.1371/journal.pone.0213556] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
18 Schnittman SR, Deitchman AN, Beck-Engeser G, Ahn H, York VA, Hartig H, Hecht FM, Martin JN, Deeks SG, Aweeka FT, Hunt PW. Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus. J Infect Dis 2021;223:1621-30. [PMID: 32915986 DOI: 10.1093/infdis/jiaa580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Li Y, Nouraie SM, Kessinger C, Weinman R, Huang L, Greenblatt RM, Kleerup E, Kingsley L, McMahon D, Fitzpatrick M, Morris A. Factors Associated With Progression of Lung Function Abnormalities in HIV-Infected Individuals. J Acquir Immune Defic Syndr 2018;79:501-9. [PMID: 30142142 DOI: 10.1097/QAI.0000000000001840] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Head BM, Mao R, Keynan Y, Rueda ZV. Inflammatory mediators and lung abnormalities in HIV: A systematic review. PLoS One 2019;14:e0226347. [PMID: 31830103 DOI: 10.1371/journal.pone.0226347] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
21 North CM, Allen JG, Okello S, Sentongo R, Kakuhikire B, Ryan ET, Tsai AC, Christiani DC, Siedner MJ. HIV Infection, Pulmonary Tuberculosis, and COPD in Rural Uganda: A Cross-Sectional Study. Lung 2018;196:49-57. [PMID: 29260309 DOI: 10.1007/s00408-017-0080-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
22 MacDonald DM, Melzer AC, Collins G, Avihingsanon A, Crothers K, Ingraham NE, Mugerwa H, Ristola M, Shuter J, Kunisaki KM; INSIGHT START Pulmonary Substudy Group. Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the START Pulmonary Substudy. J Acquir Immune Defic Syndr 2018;79:e85-92. [PMID: 29985804 DOI: 10.1097/QAI.0000000000001797] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]